DNA Damage Clinical Trial
Official title:
Double Blind, Randomized, Placebo-controlled Clinical Trial of the Effect of Noni Juice on Lipid Peroxidation-derived DNA Adducts in Current Heavy Smokers
Verified date | September 2019 |
Source | Tahitian Noni International, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study was to determine if noni juice reduces lipid hydroperoxide (LOOH) and malondialdehyde (MDA) derived-DNA adducts, markers of oxidative DNA damage, in peripheral blood lymphocytes of cigarette smokers.
Status | Completed |
Enrollment | 317 |
Est. completion date | August 2006 |
Est. primary completion date | November 2005 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - 18 to 65 years in age, smoker of more than 20 cigarettes per day, a smoking history exceeding one year, and willing to complete a one month trial. Exclusion Criteria: - concurrent use, or use in the previous three months, of prescription medication or antioxidant vitamins |
Country | Name | City | State |
---|---|---|---|
United States | University of Illinois College of Medicine at Rockford | Rockford | Illinois |
Lead Sponsor | Collaborator |
---|---|
Tahitian Noni International, Inc. | University of Illinois at Chicago |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | LOOH and MDA-DNA adducts | LOOH and MDA-DNA adducts in lymphocytes immediately prior to intervention and at completion of intervention. | 1 month | |
Secondary | adverse events | Adverse health events | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04372914 -
Prevention of Oral DNA Damage by Black Raspberries
|
N/A | |
Terminated |
NCT03893617 -
Brief Stresses Experimental Study
|
Phase 1 | |
Completed |
NCT03319654 -
Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle
|
N/A | |
Active, not recruiting |
NCT06204523 -
Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer
|
||
Completed |
NCT02696811 -
The Effects of Foods on Cell Damage Study
|
N/A | |
Completed |
NCT01461395 -
Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm
|
N/A | |
Recruiting |
NCT04081428 -
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT
|
||
Not yet recruiting |
NCT05558046 -
Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique
|
||
Recruiting |
NCT04795440 -
Comparison of ICSI Outcomes in Cycles Using Testicular and Ejaculate Sperm From Couples With High SDF
|
N/A | |
Completed |
NCT05306002 -
Nutritional Intervention and DNA Damage of Patients With HBOC
|
N/A | |
Completed |
NCT04772703 -
DNA Damage in Critically Ill COVID-19 Patients
|
||
Completed |
NCT05111717 -
The Effect of Desfluran On Global Dna Methylation
|
||
Recruiting |
NCT05596149 -
Assessment of the Cytotoxic and Genotoxic Effect of Toothpastes With Different Forms of Fluoride on the Buccal Mucosa
|
N/A | |
Recruiting |
NCT03908736 -
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
|
N/A | |
Completed |
NCT04721938 -
Healthy Parents - Healthy Children. Weight Loss Before Fertility Treatment
|
N/A | |
Recruiting |
NCT03652142 -
Predictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell Carcinoma
|
||
Completed |
NCT00854178 -
Toxicogenomic and Immunocytotoxic Effects of Propofol and Isoflurane Anesthetics in Patients Undergoing Elective Surgery
|
Phase 4 | |
Active, not recruiting |
NCT05277961 -
Quantification of DNA Repair Products in the Urine After Ultraviolet Radiation of the Skin
|
N/A | |
Completed |
NCT02058082 -
Testicular Versus Ejaculated Spermatozoa for IVF/ICSI in Men With High Sperm DNA Damage
|
N/A | |
Completed |
NCT05007171 -
Changes in Anthropometric, Biochemical and DNA Damage Parameters After 3-weeks VLCD in Severely Obese Patients
|
N/A |